PHARMACOLOGIC TREATMENT OF WET TYPE AGE-RELATED MACULAR DEGENERATION, CURRENT AND EVOLVING THERAPIES

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SHAMS NAJAFABADI HODA; DAFTARIAN NARSIS; AHMADIEH HAMID; SOHEILI ZAHRA SOHEILA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ARCHIVES OF IRANIAN MEDICINE Year:2017 | Volume:20 | Issue:8 Page(s): 525-537

Download Full-Text

View:

265

Download:

465

Cites:

Information Journal Paper

Title

PHARMACOLOGIC TREATMENT OF WET TYPE AGE-RELATED MACULAR DEGENERATION, CURRENT AND EVOLVING THERAPIES

Author(s)

SHAMS NAJAFABADI HODA | DAFTARIAN NARSIS | AHMADIEH HAMID | SOHEILI ZAHRA SOHEILA | Issue Writer Certificate

Keywords

AGE-RELATED MACULAR DEGENERATION

ANGIOGENESIS

ANTI-ANGIGENESIS DRUGS

ANTI-INFLAMMATORY DRUGS

INFLAMMATION

Abstract

AGE-RELATED MACULAR DEGENERATION as the major cause of blindness in the elderly population has remained at the epicenter of clinical research in ophthalmology. This retinal disorder is characterized by the photoreceptor and retinal pigment epithelial cells loss, occurring within the macula. The disease represents a spectrum of clinical manifestations. It is a multifactorial disease resulting from a combination of genetic predispositions and environmental risk factors. AMD is classified into two different types, dry and wet. Wet AMD is in close relation with ANGIOGENESIS and inflammatory processes.A variety of anti-angiogenesis and ANTI-INFLAMMATORY DRUGS have been proposed for the treatment of the disease. The purpose of this paper is to briefly review the pharmacological therapies of the wet form of AMD and focus on new drugs that are currently in different stages of research and development.

Cites

No record.

References

No record.

Cite

APA: Copy

SHAMS NAJAFABADI, HODA, DAFTARIAN, NARSIS, AHMADIEH, HAMID, & SOHEILI, ZAHRA SOHEILA. (2017). PHARMACOLOGIC TREATMENT OF WET TYPE AGE-RELATED MACULAR DEGENERATION, CURRENT AND EVOLVING THERAPIES. ARCHIVES OF IRANIAN MEDICINE, 20(8), 525-537. SID. https://sid.ir/paper/281503/en

Vancouver: Copy

SHAMS NAJAFABADI HODA, DAFTARIAN NARSIS, AHMADIEH HAMID, SOHEILI ZAHRA SOHEILA. PHARMACOLOGIC TREATMENT OF WET TYPE AGE-RELATED MACULAR DEGENERATION, CURRENT AND EVOLVING THERAPIES. ARCHIVES OF IRANIAN MEDICINE[Internet]. 2017;20(8):525-537. Available from: https://sid.ir/paper/281503/en

IEEE: Copy

HODA SHAMS NAJAFABADI, NARSIS DAFTARIAN, HAMID AHMADIEH, and ZAHRA SOHEILA SOHEILI, “PHARMACOLOGIC TREATMENT OF WET TYPE AGE-RELATED MACULAR DEGENERATION, CURRENT AND EVOLVING THERAPIES,” ARCHIVES OF IRANIAN MEDICINE, vol. 20, no. 8, pp. 525–537, 2017, [Online]. Available: https://sid.ir/paper/281503/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops